A comparative study of the effects of glucocorticoid and ovariectomy on bone mass and metabolism in rats

宋佳峻,罗卓荆,刘建,杨柳

DOI: https://doi.org/10.3969/j.issn.2095-252X.2013.02.006

2013-01-01

Abstract:Objective To investigate the effects of different dosages of glucocorticoid (GC) on bone mass and metabolism in rats, and to compare the different effects on bone mass and metabolism in rats between GC-induced osteoporosis model (GIOP model) and ovariectomy-induced osteoporosis model (OVX model). Methods A total of 75 4-month-old female Sprague-Dawley (SD) rats were randomly divided into 5 groups: group A (the control group) was treated with salt solution lavage (group Sham); group B was treated with low-dose GC (2.5 mg/kg prednisolone lavage each day); group C was treated with moderate-dose GC (5 mg/kg prednisolone lavage each day); group D was treated with high-dose GC (10 mg/kg prednisolone lavage each day); group E received ovariectomy (group OVX). The rats in the GC groups received lavage once per day, which lasted for 12 weeks. 5 SD rats were chosen randomly from all the groups at the 4th, 8th and 12th weeks after receiving lavage or castrating. They were sacrificed to collect the femoral metaphysis to process undecalcified bone histomorphometry and examine the lumbar 1 section by micro-CT. Enzyme-linked immunosorbent assay (ELISA) was used to test the tartrate-resistant acid phosphatase (TRACP), alkaline phosphatase (G-ALP), bone gla protein (BGP) in venous blood and deoxypyridinoline (DPD) in urine. Results (1) After 4 weeks, the trabecular bone of the experimental groups was gradually sparse and apparently necking, along with the widened spacing. With the prolongation of medication, the changes became more obvious. (2) Detection of bone mineral density: bone loss of the low-dose GC group became obvious after 8 weeks’ treatment, when compared with that of the control group (P<0.05), and while bone loss of the medium-dose GC and high-dose GC groups was significantly obvious after 4 weeks’ treatment (P<0.05). There were no significant differences in bone loss between the medium-dose GC group and high-dose GC group in each time period (P>0.05). When compared with that of the medium-dose GC and high-dose GC groups, bone loss of the castration group (group E) was significantly different at the 4th week after treatment (P<0.05), without significantly differences at the 8th and 12th weeks (P>0.05). (3) An overview of biochemical markers of bone metabolism: 4 weeks after lavage and ovariectomy, the differences in bone formation markers (G-ALP and BGP) and bone resorption markers (TRACP and DPD) of the group C, group D and group E were statistically significant, when compared with that of the control group (group A) (P<0.05). Conclusions (1) Bone loss in rats will increase along with the increasing dose of GC in a concentration-dependent manner. (2) Bone reconstruction ability in the OVX model is obviously increased, which is reduced in the GIOP model.